WallStreetZenWallStreetZen

NASDAQ: GRTS
Gritstone Bio Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

GRTS past revenue growth

How has GRTS's revenue growth performed historically?
Company
-18.05%
Industry
145.22%
Market
17.76%
GRTS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GRTS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
GRTS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

GRTS earnings and revenue history

Current Revenue
$16.3M
Current Earnings
-$138.5M
Current Profit Margin
-847.3%

GRTS Return on Equity

Current Company
-147.2%
Current Industry
-63.5%
Current Market
188%
GRTS's Return on Equity (-147.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GRTS announces earnings.

GRTS Return on Assets

Current Company
-69.5%
Current Industry
2.9%
GRTS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GRTS Return on Capital Employed

Current Company
-89.38%
Current Industry
19.5%
GRTS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GRTS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GRTS$16.34M-$112.80M-$138.49M+68.96%N/A
BTAI$1.38M-$165.42M-$179.05M+268.00%N/A
LPTX$0.00-$81.40M-$81.41M-100.00%N/A
ANVS$0.00-$56.20M-$56.20MN/AN/A
SPRO$103.78M$25.77M$22.81M+92.11%N/A
View Top Biotech Stocks

GRTS earnings dates

Next earnings date
Jun 14, 2024

Gritstone Bio Earnings & Revenue FAQ

What were GRTS's earnings last quarter?

On Invalid Date, Gritstone Bio (NASDAQ: GRTS) reported Q4 2023 earnings per share (EPS) of -$0.26, up 13.33% year over year. Total Gritstone Bio earnings for the quarter were -$30.82 million. In the same quarter last year, Gritstone Bio's earnings per share (EPS) was -$0.30.

If you're new to stock investing, here's how to buy Gritstone Bio stock.

What was GRTS's earnings growth in the past year?

As of Q2 2024, Gritstone Bio's earnings has grown year over year. Gritstone Bio's earnings in the past year totalled -$138.49 million.

What is GRTS's earnings date?

Gritstone Bio's earnings date is Invalid Date. Add GRTS to your watchlist to be reminded of GRTS's next earnings announcement.

What was GRTS's revenue last quarter?

On Invalid Date, Gritstone Bio (NASDAQ: GRTS) reported Q4 2023 revenue of $10.38 million up 143.62% year over year. In the same quarter last year, Gritstone Bio's revenue was $4.26 million.

What was GRTS's revenue growth in the past year?

As of Q2 2024, Gritstone Bio's revenue has grown -18.05% year over year. This is 163.28 percentage points lower than the US Biotechnology industry revenue growth rate of 145.22%. Gritstone Bio's revenue in the past year totalled $16.34 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.